W22
     RDKit          3D

 17 18  0  0  0  0  0  0  0  0999 V2000
    1.1536    0.0338   -0.1482 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3764   -0.0073   -0.0158 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2739    1.2428   -0.2269 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.1532    1.0900   -1.4780 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4032    0.7293   -2.7288 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6501    1.5238   -3.7877 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6805   -0.2502   -2.8491 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0400   -1.1815    0.2780 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1725   -2.2683   -0.6814 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7589   -1.2267    1.5220 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1181   -0.6110    1.4042 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2611    0.7703    1.1883 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1686    1.5969    0.9193 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2459   -1.4445    1.4555 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5208   -0.9122    1.3198 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6759    0.4633    1.1777 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5552    1.3039    1.1455 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  2  8  1  0
  3  4  1  6
  3 13  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 14  1  0
 12 13  1  0
 12 17  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
M  END
>  <DRUGBANK_ID>  (1) 
DB08717

>  <COMMON_NAME>  (1) 
[(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid

$$$$
